Autologous Platelet-Rich Plasma Eye Drops for the Treatment of Post-LASIK Chronic Ocular Surface Syndrome
Purpose. To evaluate the efficacy of autologous platelet-rich plasma (E-PRP) eye drops for the treatment of chronic ocular surface syndrome (OSS) following laser in situ keratomileusis (LASIK). Methods. This prospective interventional consecutive clinical study include 156 eyes of 80 patients affect...
Main Authors: | Jorge L. Alio, Alejandra E. Rodriguez, Ahmed A. Abdelghany, Renan F. Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2017/2457620 |
Similar Items
-
Autologous platelet-rich plasma eye drops accelerate re-epithelialization of post-keratoplasty persistent corneal epithelial defects
by: Shaban Alizadeh, et al.
Published: (2019-01-01) -
Platelet-rich autologous plasma: what is it and for what?
by: V. L. Medvedev, et al.
Published: (2020-07-01) -
Comparative efficacy of autologous alveolar bone grafting with autologous platelet-rich plasma and without platelet-rich plasma in cleft alveolus patients
by: Rohan Suhas Deshpande, et al.
Published: (2017-01-01) -
Autologous platelet-rich plasma enriched pixel grafting
by: Padmalakshmi Bharathi Mohan, et al.
Published: (2020-01-01) -
The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study
by: Antonio M. Fea, et al.
Published: (2016-01-01)